首页> 外文期刊>Experimental and clinical transplantation >Detection of Hepatis C Virus-Related Immunologic Markers and Their Impact on Outcomes of Living-Donor Kidney Transplant Recipients
【24h】

Detection of Hepatis C Virus-Related Immunologic Markers and Their Impact on Outcomes of Living-Donor Kidney Transplant Recipients

机译:丙型肝炎病毒相关免疫学标记的检测及其对活体肾脏移植受者结果的影响

获取原文
           

摘要

Objectives: Liver disease is an important cause of morbidity and mortality among recipients of transplanted organs. In addition to the liver, hepatitis C virus infection has a significant prevalence among recipients of kidney transplant and is related to worse graft and recipient survival as the kidney is an important component of the hepatitis C virus clinical syndrome. Materials and Methods: This retrospective single center study included 336 patients with end-stage renal disease who received a kidney transplant at the Mansoura Urology and Nephrology Center from January 1992 to December 1995. Of 336 patients, 63 were excluded, and the remaining 273 patients were divided into 3 groups: viremic active (72 patients), viremic inactive (108 patients), and nonviremic (93 patients). Division of patients was based on hepatitis C virus RNA complement level (C3 and/or C4 consumption), circulating cryoglobulins, and rheumatoid factor detection. Results: Our study showed insignificant differences regarding patient characteristics and demographic data among the study groups but significantly higher incidence of transaminitis in viremic (active and inactive) patients. Nonsignificant differences were found regarding proteinuria among the 3 groups, including among those who had levels in either nephrotic or nonnephrotic ranges. Biopsy-proven acute rejection episodes among the 3 groups of recipients were statistically comparable, with significantly higher frequency of chronic rejection episodes among viremic active patients. Nonviremic recipients had significantly lower serum creatinine levels than viremic (active and inactive) recipients. Patient and graft survival results were comparable among the groups. Conclusions: Presence of hepatitis C virus immunologic markers does not have a significant effect on patient and graft survival; however, it may be a clue for long-term incidence of chronic rejection.
机译:目的:肝病是器官移植患者发病和死亡的重要原因。除肝脏外,丙型肝炎病毒感染在肾移植接受者中也很普遍,并且与较差的移植物和受体存活率有关,因为肾脏是丙型肝炎病毒临床综合征的重要组成部分。资料和方法:这项回顾性单中心研究纳入了1992年1月至1995年12月在Mansoura泌尿外科和肾脏病中心接受肾脏移植的336例终末期肾脏疾病患者。在336例患者中,有63例被排除在外,其余273例分为3组:病毒血症活动型(72例),病毒血症无效型(108例)和非病毒血症(93例)。患者的分型基于丙型肝炎病毒RNA补体水平(C3和/或C4消耗量),循环球蛋白和类风湿因子检测。结果:我们的研究显示,研究组之间在患者特征和人口统计学数据方面差异不显着,但在病毒血症(活动和非活动)患者中,发生氨氮炎的发生率明显更高。在三组之间,包括在肾病或非肾病范围内水平的蛋白尿中,发现无显着差异。经活检证实的三组接受者之间的急性排斥反应在统计学上具有可比性,在病毒血症活跃患者中,慢性排斥反应的发生频率明显更高。非病毒血症的接受者的血清肌酐水平明显低于病毒血症(活动和非活动)的接受者。患者和移植物的存活结果在各组之间相当。结论:丙型肝炎病毒免疫标记物的存在对患者和移植物的存活没有显着影响;然而,这可能是长期排斥反应的长期线索。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号